The New England Journal of Medicine
Tirzepatide Once Weekly for the Treatment of Obesity
2022 · PMID 35658024
Jastreboff AM et al.
View source
Metabolic Compound
GLP-1 T
Tirzepatide-class dual GIP/GLP-1 receptor agonist — a 39-amino-acid acylated peptide studied in multi-incretin receptor signaling research.
Quantity
Units
1
Price
$29.99In stock
Bundle & Save
Est. delivery Thu, Jul 30–Wed, Aug 5 · COA included · Same-day ship before 2PM PT
Apple Pay · Google Pay · Visa · Amex · Discover
Compound information
Molecular profile
Technical specifications for laboratory reference
Molecular profile
What is GLP-1 T?
Tirzepatide-class dual GIP/GLP-1 receptor agonist — a 39-amino-acid acylated peptide studied in multi-incretin receptor signaling research.
- Type
- Dual incretin agonist
- CAS Number
- 2023788-19-2
- Molecular Weight
- 4,813.5 g/mol
- Amino Acids
- 39
Storage requirements
Stability information
Cold chainProtect from light
Lyophilized (powder)
−20°C · up to 24 months
Reconstituted
2–8°C · up to 14 days
Literature
Sources & references
Peer-reviewed research for laboratory background
The Lancet
Tirzepatide versus semaglutide once weekly in type 2 diabetes
2021 · PMID 34170647
Frías JP et al.
View sourceCitations are provided for research background only. Peptide Club materials are sold for laboratory research use — not for human or veterinary consumption. References do not constitute product claims.
